Vyxeos is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Vyxeos is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameVyxeos
Authorized generic(daunorubicin and cytarabine) liposome
Regular generic(daunorubicin and cytarabine) liposome
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Vyxeos?
The original
–
–

Brand nameThe maker’s card

VYXEOS Savings Card (JazzCares)

Savings card from Jazz Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a prescription

Sign up on jazzcares.com 

Or call 1-833-533-5299.

In the maker’s words

“Savings Card—If you are eligible and commercially insured, you may pay as little as $0 per prescription, subject to an annual maximum…”

From the maker’s offer on jazzcares.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Vyxeos itself, from the same company, sold without the brand name, and usually for less. For now Vyxeos is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

VYXEOS is a liposomal combination of daunorubicin, an anthracycline topoisomerase inhibitor, and cytarabine, a nucleoside metabolic inhibitor, that is indicated for the treatment of newly diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in adults and pediatric patients 1 year and older.

Source: the FDA label for Vyxeos (Jazz Pharmaceuticals, Inc.), January 30, 2026. Full label on DailyMed 

Good to know